Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
Abbott trades at half Lilly's valuation multiple, but Lilly's 45% revenue surge and 32% net margin raise the stakes for growth-focused investors.
Why it matters
Attributed market update with source link for portfolio context.